A review of clinical studies with combinations of fluphenazine and nortriptyline.
D000639:Amitriptyline / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy*; D002490:Central Nervous System / Q000187:drug effects; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D004316:Doxepin / Q000627:therapeutic use; D004338:Drug Combinations; D005476:Fluphenazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D009043:Motor Activity / Q000187:drug effects; D009661:Nortriptyline / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010546:Perphenazine / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014786:Vision Disorders / Q000139:chemically induced
D004338:Drug Combinations; D010919:Placebos; D004316:Doxepin; D000639:Amitriptyline; D009661:Nortriptyline; D010546:Perphenazine; D003975:Diazepam; D005476:Fluphenazine